
Spikevax
Product
by Moderna, Inc.
Spikevax is an mRNA vaccine developed to prevent COVID-19 caused by SARS-CoV-2. It delivers messenger RNA instructions that prompt cells to produce a viral spike protein, helping the immune system develop protective responses; updated formulations target circulating variants.

